These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8599173)

  • 21. CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses.
    Carbone T; Nasorri F; Pennino D; Eyerich K; Foerster S; Cifaldi L; Traidl-Hoffman C; Behrendt H; Cavani A
    J Immunol; 2010 Jan; 184(2):1102-10. PubMed ID: 20008290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of drug allergy--current concepts and recent insights.
    Schnyder B; Brockow K
    Clin Exp Allergy; 2015 Sep; 45(9):1376-83. PubMed ID: 26172398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.
    Martin S; Ortmann B; Pflugfelder U; Birsner U; Weltzien HU
    J Immunol; 1992 Oct; 149(8):2569-75. PubMed ID: 1383319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic and irritant contact dermatitis.
    Nosbaum A; Vocanson M; Rozieres A; Hennino A; Nicolas JF
    Eur J Dermatol; 2009; 19(4):325-32. PubMed ID: 19447733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen receptors on Thy-1+ CD3- CS-initiating cell. In vitro desensitization with hapten-amino acid or hapten-Ficoll conjugates, versus hapten-protein conjugates, suggests different antigen receptors on the immune cells that mediate the early and late components of murine contact sensitivity.
    Garssen J; Van Loveren H; Kato K; Askenase PW
    J Immunol; 1994 Jul; 153(1):32-44. PubMed ID: 7911496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes.
    Gaspari AA; Katz SI
    J Immunol; 1991 Dec; 147(12):4155-61. PubMed ID: 1753091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of epitopes recognized by hapten-specific CD4+ T cells.
    Cavani A; Hackett CJ; Wilson KJ; Rothbard JB; Katz SI
    J Immunol; 1995 Feb; 154(3):1232-8. PubMed ID: 7529797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathomechanisms of the elicitation phase of allergic contact dermatitis].
    Riemann H; Schwarz T; Grabbe S
    J Dtsch Dermatol Ges; 2003 Aug; 1(8):613-9. PubMed ID: 16296151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of murine contact sensitivity by hapten-amino acid derivatives.
    Satoh T; Yokozeki H; Katayama I; Nishioka K
    Int Arch Allergy Immunol; 1993; 102(1):94-100. PubMed ID: 8400890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effector and regulatory mechanisms in allergic contact dermatitis.
    Vocanson M; Hennino A; Rozières A; Poyet G; Nicolas JF
    Allergy; 2009 Dec; 64(12):1699-714. PubMed ID: 19839974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene.
    Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF
    Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of resolution of allergic contact dermatitis.
    Gaspari AA
    Am J Contact Dermat; 1996 Dec; 7(4):212-9. PubMed ID: 8955483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caged fluorescent haptens reveal the generation of cryptic epitopes in allergic contact dermatitis.
    Simonsson C; Andersson SI; Stenfeldt AL; Bergström J; Bauer B; Jonsson CA; Ericson MB; Broo KS
    J Invest Dermatol; 2011 Jul; 131(7):1486-93. PubMed ID: 21228815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating chemistry and immunology in allergic contact dermatitis: more questions than answers?
    Lonsdorf AS; Enk AH
    J Invest Dermatol; 2011 Jul; 131(7):1406-8. PubMed ID: 21673709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine.
    Jenkinson C; Jenkins RE; Maggs JL; Kitteringham NR; Aleksic M; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2009 Jun; 22(6):1172-80. PubMed ID: 19469519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview.
    Büdinger L; Hertl M
    Allergy; 2000 Feb; 55(2):108-15. PubMed ID: 10726725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes.
    Martin S; von Bonin A; Fessler C; Pflugfelder U; Weltzien HU
    J Immunol; 1993 Jul; 151(2):678-87. PubMed ID: 8335903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protective role of complement component 3 in T cell-mediated skin inflammation.
    Purwar R; Bäumer W; Niebuhr M; Tschernig T; Kietzmann M; Werfel T
    Exp Dermatol; 2011 Sep; 20(9):709-14. PubMed ID: 21569105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.